Impact of viability and scar tissue on response to cardiac resynchronization therapy in ischaemic heart failure patients

被引:307
作者
Ypenburg, Claudia
Schalij, Martin J.
Bleeker, Gabe B.
Steendijk, Paul
Boersma, Eric
Dibbets-Schneider, Petra
Stokkel, Marcel P. M.
van der Wall, Ernst E.
Bax, Jeroen J.
机构
[1] Leiden Univ, Med Ctr, Dept Cardiol, NL-2333 ZA Leiden, Netherlands
[2] Erasmus Univ, Dept Epidemiol & Stat, Rotterdam, Netherlands
[3] Leiden Univ, Med Ctr, Dept Nucl Med, NL-2333 ZA Leiden, Netherlands
关键词
cardiac resynchronization therapy; heart failure; nuclear imaging; viability;
D O I
10.1093/eurheartj/ehl379
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims At present, 20-30% of patients do not respond to cardiac resynchronization therapy (CRT). In this study, the relation between the extent of viable myocardium and scar tissue vs. response to CRT was evaluated. In addition, the presence of scar tissue in the left ventricular (LV) lead position was specifically related to response to CRT. Methods and results A total of 51 consecutive patients with ischaemic heart failure and substantial LV dyssynchrony undergoing CRT were included. All patients underwent gated SPECT before CRT implantation to determine the extent of scar tissue and viable myocardium. Clinical and echocardiographic parameters were assessed at baseline and after 6 months of CRT. The results demonstrated direct relations between the response to CRT and the extent of viable myocardium and scar tissue. In addition, the 15 patients (29%) with transmural scar tissue (< 50% tracer activity) in the region of the LV pacing lead showed no improvement after 6 months of CRT. Conclusion The extent of scar tissue and viable myocardium were directly related to the response to CRT. Furthermore, scar tissue in the LV pacing lead region may prohibit response to CRT. Evaluation for viability and scar tissue may be considered in the selection process for CRT.
引用
收藏
页码:33 / 41
页数:9
相关论文
共 29 条
[1]   Cardiac resynchronization in chronic heart failure [J].
Abraham, WT ;
Fisher, WG ;
Smith, AL ;
Delurgio, DB ;
Leon, AR ;
Loh, E ;
Kocovic, DZ ;
Packer, M ;
Clavell, AL ;
Hayes, DL ;
Ellestad, M ;
Messenger, J ;
Trupp, RJ ;
Underwood, J ;
Pickering, F ;
Truex, C ;
McAtee, P .
NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (24) :1845-1853
[2]   Quantification of SPECT myocardial perfusion imaging [J].
Acampa, W ;
He, W ;
di Nuzzo, C ;
Cuocolo, A .
JOURNAL OF NUCLEAR CARDIOLOGY, 2002, 9 (03) :338-342
[3]   Electrocardiographic predictive factors of long-term clinical improvement with multisite biventricular pacing in advanced heart failure [J].
Alonso, C ;
Leclercq, C ;
Victor, F ;
Mansour, H ;
de Place, C ;
Pavin, D ;
Carré, F ;
Mabo, P ;
Daubert, JC .
AMERICAN JOURNAL OF CARDIOLOGY, 1999, 84 (12) :1417-1421
[4]   Left ventricular dyssynchrony predicts benefit of cardiac resynchronization therapy in patients with end-stage heart failure before pacemaker implantation [J].
Bax, JJ ;
Marwick, TH ;
Molhoek, SG ;
Bleeker, GB ;
van Erven, L ;
Boersma, E ;
Steendijk, P ;
van der Wall, EE ;
Schalij, MJ .
AMERICAN JOURNAL OF CARDIOLOGY, 2003, 92 (10) :1238-1240
[5]   Left ventricular dyssynchrony predicts response and prognosis after cardiac resynchronization therapy [J].
Bax, JJ ;
Bleeker, GB ;
Marwick, TH ;
Molhoek, SG ;
Boersma, E ;
Steendijk, P ;
van der Wall, EE ;
Schalij, MJ .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 44 (09) :1834-1840
[6]  
BAX JJ, 2004, HEART, V90, P26
[7]   Effect of posterolateral scar tissue on clinical and echocardiographic improvement after cardiac resynchronization therapy [J].
Bleeker, GB ;
Kaandorp, TAM ;
Lamb, HJ ;
Boersma, E ;
Steendijk, P ;
de Roos, A ;
van der Wall, EE ;
Schalij, MJ ;
Bax, JJ .
CIRCULATION, 2006, 113 (07) :969-976
[8]   Frequency of left ventricular dyssynchrony in patients with heart failure and a narrow QRS complex [J].
Bleeker, GB ;
Schalij, MJ ;
Molhoek, SG ;
Holman, ER ;
Verwey, HF ;
Steendijk, P ;
van der Wall, EE ;
Bax, JJ .
AMERICAN JOURNAL OF CARDIOLOGY, 2005, 95 (01) :140-142
[9]   Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure [J].
Bristow, MR ;
Saxon, LA ;
Boehmer, J ;
Krueger, S ;
Kass, DA ;
De Marco, T ;
Carson, P ;
DiCarlo, L ;
DeMets, D ;
White, BG ;
DeVries, DW ;
Feldman, AM .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (21) :2140-2150
[10]   Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay. [J].
Cazeau, S ;
Leclercq, C ;
Lavergne, T ;
Walker, S ;
Varma, C ;
Linde, C ;
Garrigue, S ;
Kappenberger, L ;
Haywood, GA ;
Santini, M ;
Bailleul, C ;
Daubert, JC .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (12) :873-880